Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-10

FDA Approved: SALAGEN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approved a supplemental application for SALAGEN (pilocarpine hydrochloride) filed by Advanz Pharma (US) Corp. The approval updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SALAGEN (Pilocarpine hydrochloride)

Snippet

SUPPL AP for SALAGEN (PILOCARPINE HYDROCHLORIDE)